Gliclazide + Metformin

Composition

Gliclazide + Metformin is a combination of two oral antidiabetic agents widely used in the LATAM region. Gliclazide is a sulfonylurea that stimulates insulin secretion, while Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. This effective combination helps manage blood sugar levels in patients with type 2 diabetes.

Indications

This combination is indicated for the management of type 2 diabetes mellitus, particularly in patients who do not achieve adequate glycemic control with diet and exercise alone.

Side effects

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort. Other potential side effects include hypoglycemia (low blood sugar), allergic reactions, and lactic acidosis, particularly in patients with renal impairment.

Precautions

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort. Other potential side effects include hypoglycemia (low blood sugar), allergic reactions, and lactic acidosis, particularly in patients with renal impairment.

Contraindications

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort. Other potential side effects include hypoglycemia (low blood sugar), allergic reactions, and lactic acidosis, particularly in patients with renal impairment.

Dosage and administration

As directed by the physician.

Countries

Gliclazide + Metformin is widely available in various LATAM countries, including Brazil, Mexico, Argentina, Chile, and Colombia.

Available Forms

The combination is available in various forms, including tablets in different strengths to accommodate individualized treatment regimens.

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai